Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8043704rdf:typepubmed:Citationlld:pubmed
pubmed-article:8043704lifeskim:mentionsumls-concept:C0020962lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0034819lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0023870lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0242485lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C2705716lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0031082lld:lifeskim
pubmed-article:8043704lifeskim:mentionsumls-concept:C0439590lld:lifeskim
pubmed-article:8043704pubmed:issue10lld:pubmed
pubmed-article:8043704pubmed:dateCreated1994-8-30lld:pubmed
pubmed-article:8043704pubmed:abstractTextThe purpose of this study was to begin evaluating the effects of lithium carbonate on in vivo immune function in normal controls. We postulated that lithium carbonate would stimulate lymphocytes but would not affect the production of antithyroid antibodies. Twenty-seven normal controls had blood samples drawn for measurements of serum soluble interleukin-2 receptors (SIL-2Rs), antithyroglobulin antibodies, and antimicrosomal antibodies prior to and after approximately 1 and 4 weeks of treatment with lithium carbonate at therapeutic blood levels. Subjects had a small but statistically significant increase in serum SIL-2Rs after 4 weeks of lithium treatment (446.3 +/- 177.2 U/ml versus 497.6 +/- 232.3 U/ml, p = 0.033). There was no increase in the prevalence of antithyroglobulin or antimicrosomal antibodies with lithium treatment nor did lithium act as an adjuvant to increase the titers in subjects with preexisting antithyroid antibodies.lld:pubmed
pubmed-article:8043704pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:languageenglld:pubmed
pubmed-article:8043704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:citationSubsetIMlld:pubmed
pubmed-article:8043704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8043704pubmed:statusMEDLINElld:pubmed
pubmed-article:8043704pubmed:monthMaylld:pubmed
pubmed-article:8043704pubmed:issn0006-3223lld:pubmed
pubmed-article:8043704pubmed:authorpubmed-author:SchmidtM EMElld:pubmed
pubmed-article:8043704pubmed:authorpubmed-author:ManjiHHlld:pubmed
pubmed-article:8043704pubmed:authorpubmed-author:RapaportM HMHlld:pubmed
pubmed-article:8043704pubmed:authorpubmed-author:RisingerRRlld:pubmed
pubmed-article:8043704pubmed:issnTypePrintlld:pubmed
pubmed-article:8043704pubmed:day15lld:pubmed
pubmed-article:8043704pubmed:volume35lld:pubmed
pubmed-article:8043704pubmed:ownerNLMlld:pubmed
pubmed-article:8043704pubmed:authorsCompleteYlld:pubmed
pubmed-article:8043704pubmed:pagination761-6lld:pubmed
pubmed-article:8043704pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:meshHeadingpubmed-meshheading:8043704-...lld:pubmed
pubmed-article:8043704pubmed:year1994lld:pubmed
pubmed-article:8043704pubmed:articleTitleThe effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements.lld:pubmed
pubmed-article:8043704pubmed:affiliationDepartment of Psychiatry, University of California, San Diego School of Medicine, La Jolla 92093-0655.lld:pubmed
pubmed-article:8043704pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8043704pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8043704pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8043704pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8043704pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed